GLP-1, or {glucagon-like|glucagon like|glucagon) peptide-1, is rapidly emerging as a prominent focus in medical investigation, largely due to its notable impact on treating diseases such as adult-onset diabetes and weight gain. New trials have shown that beyond glucose management, GLP-1 agonists